NDATOPICALEMULSION
Approved
Sep 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 5h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HEXA-GERM is a topical antimicrobial emulsion containing hexachlorophene, approved in 1974 for skin antisepsis and antimicrobial applications. The drug works through direct antimicrobial action on bacterial cell membranes, making it effective for topical infection prevention and wound care. It represents a legacy small-molecule antiseptic with a long commercial history.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100); team size and hiring likely constrained as brand transitions to mature/defensive positioning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Why This Matters for Your Career
Medica Corp is hiring 4 roles related to this product
Worked on HEXA-GERM at Medica Corp? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.